| ≤5 years | 5.1–10 years | 10.1–15 years | 15.1–20 years | >20 years | |||||
---|---|---|---|---|---|---|---|---|---|---|
% | 95Â % CI | % | 95Â % CI | % | 95Â % CI | % | 95Â % CI | % | 95Â % CI | |
Malaria outcomes | ||||||||||
 RDT Pos | 4.1 | 2.7–5.4 | 6.1 | 4.2–8.0 | 4.0 | 2.2–5.8 | 2.6 | 1.0–4.5 | 1.0 | 0.4–1.4 |
 PCR Pos | 7.8 | 5.9–9.7 | 13.1 | 10.4–15.7 | 10.4 | 7.5–13.2 | 10.6 | 6.9–14.4 | 6.0 | 4.8–7.2 |
 Sub-patent | 51.3 | 39.7–63.0 | 61.5 | 51.3–71.7 | 61.8 | 48.6–75.1 | 78.1 | 63.0–93.3 | 73.3 | 64.7–81.9 |
Malaria factors | ||||||||||
 Bed net use | 60.7 | 57.3–64.1 | 61.1 | 57.3–65.0 | 55.6 | 51.0–60.2 | 56.5 | 50.6–62.5 | 61.9 | 59.4–64.4 |
 Travel | 2.5 | 1.4–3.6 | 1.7 | 0.6–2.7 | 1.4 | 0.3–2.5 | 3.9 | 1.5–6.3 | 9.0 | 7.5–10.5 |
 Anaemic | 41.6 | 38.2–45.0 | 22.9 | 19.6–26.3 | 13.9 | 10.7–17.1 | 16.8 | 12.3–21.4 | 23.3 | 21.1–25.5 |